4//SEC Filing
Edge Therapeutics, Inc. 4
Accession 0001127602-16-059802
$PDSBCIK 0001472091operating
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 9:23 AM ET
Size
6.2 KB
Accession
0001127602-16-059802
Insider Transaction Report
Form 4
MIDDLEKAUFF W BRADFORD
Senior VP, GC and Secretary
Transactions
- Purchase
Common Stock
2016-08-08$9.43/sh+143$1,348→ 10,000 total - Purchase
Common Stock
2016-08-05$9.48/sh+9,857$93,444→ 9,857 total
Footnotes (1)
- [F1]The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $9.42 to $9.60 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001472091
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 9:23 AM ET
- Size
- 6.2 KB